“As the first gene therapy candidate for hemophilia B, this pivotal regulatory milestone brings CSL Behring one step closer to delivering on the ...
https://www.google.com/url?rct=j&sa=t&url=https://eturbonews.com/3064141/new-gene-therapy-for-patients-with-hemophilia-b/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNExgAXjrNvKiGul_UisVO9uYt2yFw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.